HK Stock MarketDetailed Quotes

LUZHU BIOTECH-B (02480)

Watchlist
  • 19.820
  • -0.020-0.10%
Market Closed May 14 14:38 CST
3.94BMarket Cap-23.68P/E (TTM)

LUZHU BIOTECH-B (02480) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
免疫检测试剂盒销售收入3.37M30.58%
与以下各项有关的政府补助-厂房及机器3.02M27.33%
与以下各项有关的政府补助-使用权资产2.67M24.20%
银行结余利息收入1.16M10.52%
与以下各项有关的政府补助-研发活动500K4.53%
与以下各项有关的政府补助-其他216K1.96%
Property rental income75K0.68%
租赁按金利息收入21K0.19%
View all

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
免疫检测试剂盒销售收入3.37M30.58%
与以下各项有关的政府补助-厂房及机器3.02M27.33%
与以下各项有关的政府补助-使用权资产2.67M24.20%
银行结余利息收入1.16M10.52%
与以下各项有关的政府补助-研发活动500K4.53%
与以下各项有关的政府补助-其他216K1.96%
Property rental income75K0.68%
租赁按金利息收入21K0.19%
View all

By Country/Region

No Data

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More